MARKET

EVFM

EVFM

Evofem Bioscienc
OTCID
0.0083
0.0000
0.00%
Closed 15:50 03/30 EDT
OPEN
0.0083
PREV CLOSE
0.0083
HIGH
0.0091
LOW
0.0083
VOLUME
11.88K
TURNOVER
107
52 WEEK HIGH
0.016
52 WEEK LOW
0.0070
MARKET CAP
1.10M
P/E (TTM)
-0.1468
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EVFM last week (0323-0327)?
Weekly Report · 16h ago
Weekly Report: what happened at EVFM last week (0316-0320)?
Weekly Report · 03/23 10:31
Weekly Report: what happened at EVFM last week (0309-0313)?
Weekly Report · 03/16 10:30
Based on the provided financial report articles, I generated the title for the article: **"Consolidated Balance Sheets and Statements of Changes in Stockholders' Equity (Deficit) for the Years Ended December 31, 2024 and 2023, and the Six Months Ended June 30, 2025"** Please note that the title may not be exact, as the provided text is a large block of financial data and may not contain a specific title. However, based on the content, I attempted to create a title that accurately reflects the information presented.
Press release · 03/12 14:11
Evofem Biosciences Reports First Year of Operating Profit
TipRanks · 03/12 01:04
Evofem Biosciences GAAP EPS of $0.00, revenue of $20.2M
Seeking Alpha · 03/11 20:34
Weekly Report: what happened at EVFM last week (0302-0306)?
Weekly Report · 03/09 10:31
Weekly Report: what happened at EVFM last week (0223-0227)?
Weekly Report · 03/02 10:30
More
About EVFM
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. The Company is commercializing its products to address unmet needs in women’s sexual and reproductive health. The Company’s first approved product, PHEXXI (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of over 12 pre-filled applicators and is applied 0-60 minutes before each act of intercourse. PHEXXI is a gel that works to prevent pregnancy without the use of hormones. PHEXXI prevents pregnancy by reducing sperm motility, inhibiting sperm from reaching the ovum to form a zygote. Using the PHEXXI telehealth platform, women can directly meet with a health care provider to determine their eligibility for a PHEXXI prescription. The Company also commercialized SOLOSEC (secnidazole) 2g oral granules, an antibiotic for the treatment of two sexual health diseases such as bacterial vaginosis and trichomoniasis.

Webull offers Evofem Biosciences Inc stock information, including OTCID: EVFM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EVFM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EVFM stock methods without spending real money on the virtual paper trading platform.